Evidence map›Paper›PMID 33338552›Full record

ArticleDiabetes research and clinical practice2021

Incidence and predictors of type 1 diabetes among younger adults aged 20-45 years: The diabetes in young adults (DiYA) study.

Jean M Lawrence, Jeff M Slezak, Charles Quesenberry, Xia Li, Liping Yu, Marian Rewers, Janet G Alexander, Harpreet S Takhar, Sneha Sridhar, Ann Albright and 4 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes research and clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Predictive Autoantibodies Before the Diagnosis of Type I Diabetes in Adults.medRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Jean M LawrenceDepartment of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles Ave, 2(nd) floor, Pasadena, CA 91101, USA. Electronic address: jean.lawrence@nih.gov.
Jeff M SlezakDepartment of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles Ave, 2(nd) floor, Pasadena, CA 91101, USA.
Charles QuesenberryDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA.
Xia LiDepartment of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles Ave, 2(nd) floor, Pasadena, CA 91101, USA.
Liping YuBarbara Davis Center for Diabetes, School of Medicine, University of Colorado, 1775 Aurora Ct, B140, Aurora, CO 80045, USA.
Marian RewersBarbara Davis Center for Diabetes, School of Medicine, University of Colorado, 1775 Aurora Ct, B140, Aurora, CO 80045, USA.
Janet G AlexanderDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA.
Harpreet S TakharDepartment of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles Ave, 2(nd) floor, Pasadena, CA 91101, USA.
Sneha SridharDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA.
Ann AlbrightDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE MS-F-73, Atlanta, GA 30341, USA.
Deborah B RolkaDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE MS-F-73, Atlanta, GA 30341, USA.
Sharon SaydahDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention, 3311 Toledo Rd Hyattsville, MD 20782, USA.
Giuseppina ImperatoreDivision of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE MS-F-73, Atlanta, GA 30341, USA.
Assiamira FerraraDivision of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA.
Kaiser Permanente · USCenters for Disease Control and Prevention · USNational Center for Chronic Disease Prevention and Health Promotion · USUniversity of Colorado Denver · US

Funding

University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Natural History of Pre-Diabetic Autoimmunity (DAISY)R01DK032493 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J · 1986 to 2024
$9.3M
Multiple Autoantigens/Multiple Epitopes of Type 1DMR01DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 1986 to 2025
$6.9M
STUDY TO ASSESS THE INCIDENCE OF TYPE 1 DIABETES IN YOUNG ADULTSU18DP006289 · DP · KAISER FOUNDATION RESEARCH INSTITUTE · PI LAWRENCE, JEAN MARIE · 2016 to 2017
$2.1M
ACL HHS U18DP006289NCCDPHP CDC HHS U18 DP006289NIDDK NIH HHS P30 DK116073NIDDK NIH HHS R01 DK032083
6 · The paper itself

Abstract

aimsTo estimate incidence of type 1 diabetes (T1D) and to develop a T1D prediction model among young adults.

methodsAdults 20-45 years newly-diagnosed with diabetes in 2017 were identified within Kaiser Permanente's healthcare systems in California and invited for diabetes autoantibody (DAA) testing. Multiple imputation was conducted to assign missing DAA status. The primary outcome for incidence rates (IR) and the prediction model was T1D defined by ≥1 positive DAA.

resultsAmong 2,347,989 persons at risk, 7862 developed diabetes, 2063 had DAA measured, and 166 (8.0%) had ≥1 positive DAA. T1D IR (95% CI) per 100,000 person-years was 15.2 (10.2-20.1) for ages 20-29 and 38.2 (28.6-47.8) for ages 30-44 years. The age-standardized IRs were 32.5 (22.2-42.8) for men and 27.2 (21.0-34.5) for women. The age/sex-standardized IRs were 30.1 (23.5-36.8) overall; 41.4 (25.3-57.5) for Hispanics, 37.0 (11.6-62.4) for Blacks, 21.4 (14.3-28.6) for non-Hispanic Whites, and 19.4 (8.5-30.2) for Asians. Predictors of T1D among cases included female sex, younger age, lower BMI, insulin use and having T1D based on diagnostic codes.

conclusionsT1D may account for up to 8% of incident diabetes cases among young adults. Follow-up is needed to establish the clinical course of patients with one DAA at diagnosis.

Indexed as

AdultAutoantibodiesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleHumansIncidenceMaleMiddle AgedYoung AdultAutoantibodiesAutoimmunityIncidence ratesPrediction modelType 1 diabetesYoung adults

Identifiers

PMID33338552
PMCPMC10116767
OpenAlexW3113148670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.